You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 16, April 28, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Surgery
 •Surgical Physiology
 •Surgical Infections
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Supplemental Oxygen and Risk of Surgical Site Infection

Since this article does not have an abstract, we have provided the first 149 words of the full text and any section headings.

To the Editor: Dr Pryor and colleagues1 did not evaluate the potential effect of hyperglycemia on rates of infection. It has been reported that controlling levels of blood glucose in the perioperative period is important in preventing deep sternal wound infections in patients with diabetes who undergo cardiac surgery.2 Unmeasured hyperglycemia may thus have been a factor in these unexpected results. Maintenance of blood glucose levels below 200 mg/dL (11.1 mmol/L) with a continuous infusion of insulin was an important determinant of avoiding a postoperative infection in cardiac surgical patients.2 Furthermore, animal studies have found that hyperoxia can lead to sustained hyperglycemia.3 Thus, I believe it would have been worthwhile to evaluate the perioperative levels of blood glucose to determine if hyperglycemia existed; and, if so, it may explain why hyperoxia was of no benefit and might possibly be related to the increased rate of infection in this study.

Martin J. O'Neill, Jr, MD
Bloomington Hospital
Bloomington, Ind

1. Pryor KO, Fahey TJ 3rd, Lien CA, Goldstein PA. Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA. 2004;291:79-87. FREE FULL TEXT
2. Furnary A, Zerr K, Grunkemeier G, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352-362. FREE FULL TEXT
3. Bandali K, Belanger M, Wittnich C. Does hyperoxia affect glucose regulation and transport in the newborn? J Thorac Cardiovasc Surg. 2003;126:1730-1735. FREE FULL TEXT

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2004;291:1958.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Supplemental Oxygen and Risk of Surgical Site Infection
Harriet W. Hopf, Thomas K. Hunt, and Noah Rosen
JAMA. 2004;291(16):1956.
EXTRACT | FULL TEXT  

Supplemental Oxygen and Risk of Surgical Site Infection
Ozan Akça and Daniel I. Sessler
JAMA. 2004;291(16):1956-1957.
EXTRACT | FULL TEXT  

Supplemental Oxygen and Risk of Surgical Site Infection
Robert Greif and Daniel I. Sessler
JAMA. 2004;291(16):1957.
EXTRACT | FULL TEXT  

Supplemental Oxygen and Risk of Surgical Site Infection
Johann Harten, Keith Anderson, and John Kinsella
JAMA. 2004;291(16):1957.
EXTRACT | FULL TEXT  

Supplemental Oxygen and Risk of Surgical Site Infection
James T. Lee
JAMA. 2004;291(16):1957-1958.
EXTRACT | FULL TEXT  

Supplemental Oxygen and Risk of Surgical Site Infection—Reply
Kane O. Pryor, Thomas J. Fahey, III, Cynthia A. Lien, and Peter A. Goldstein
JAMA. 2004;291(16):1958-1959.
EXTRACT | FULL TEXT  

Surgical Site Infection and the Routine Use of Perioperative Hyperoxia in a General Surgical Population: A Randomized Controlled Trial
Kane O. Pryor, Thomas J. Fahey, III, Cynthia A. Lien, and Peter A. Goldstein
JAMA. 2004;291(1):79-87.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.